Neurobiological Tech (NTII) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII)

NTII 0.0001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: lrb who wrote (245)	1/29/1998 8:40:00 PM
From: Peter Silsbee	Read Replies (1) of 1494

Point taken (re:safety profile)... and nobody was expecting proven efficacy from a Phase I/II trial. But still, "suggestion of potential" really isn't much. The results of the 90-patient trial will be much more convincing, one way or the other. May the potential be realized. PLS Think there'll be another release tomorrow?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next